Expression of Helper T Cell Type 17 and CD4+ CD25+ Tregs in AMA-M2 Positive PBC Patients

PAR

Proceedings of Anticancer Research

2208-35452208-3553

Bio-Byword Scientific Publishing Pty. Ltd.

10.26689/par.v6i5.4357

Article

Expression of Helper T Cell Type 17 and CD4+ CD25+ Tregs in AMA-M2 Positive PBC Patientshttps://artdesignp.com/journal/PAR/6/5/10.26689/par.v6i5.4357CaiTingting,YuYang,LiuXiuzhong,ChenZhanliang,DuanLin

2022

2022-09-28

Objective: To investigate the expression and impact of helper T cell type 17 and CD4+ CD25+ regulatory T (Treg) cells in anti-mitochondrial M2 antibody (AMA-M2) positive primary biliary cholangitis (PBC) patients. Methods: Thirty PBC patients with positive AMA (M2 type) (antibody titer above 1:320) by indirect immunofluorescence assay under the Affiliated Hospital of Hebei University from November 2021 to August 2022 were selected as the experimental group, while 30 healthy individuals were selected as controls. The subjects were observed and analyzed for AFP-L3 and immunoglobulin expression. Results: The levels of Thl7, Treg, Thl7/Treg, interleukin (IL)-17A, IL-2, IL-10, and transforming growth factor (TGF)-?1 cytokines of the experimental group were 2.61 ± 0.48, 1.15 ± 0.54, 2.41 ± 0.47, 310.94 ± 21.14, 276.36 ± 36.12, 317.89 ± 28.97, and 197.48 ± 31.04, respectively, while those of the control group were 1.14 ± 0.58, 0.88 ± 0.29, 1.47 ± 0.25, 9.69 ± 1.26, 57.69 ± 2.45, 154.01 ± 19.87, and 514.36 ± 36.12, respectively, wherein P < 0.05; the CD4+, CD8+, and CD4+/CD8+ of the experimental group were 39.48 ± 4.19, 20.12 ± 4.41, and 1.76 ± 0.14, respectively, while those of the control group were 35.78 ± 4.21, 22.01 ± 4.16, and 1.51 ± 0.13, respectively, wherein P < 0.05. Conclusion: In patients with PBC, there is a significant imbalance in Thl7/Treg cells. Il-17A, IL-2, IL-10, and TGF- ?1 cytokines play important roles in the differentiation and functional expression of both Thl7 and Treg cells.

Wu Y, Chen S, Yang C, et al., 2022, Effect of Interleukin-23 Receptor Overexpression on the Balance of Helper T Cell 17/Regulatory T Cells in Mice with Experimental Autoimmune Uveitis. Chinese Journal of Ophthalmology, 38(05): 389–395.

Zhang Z, Gan M, 2022, Significance of Serum FGF19, Klotho and FGFR4 Protein Expression in Patients with Primary Biliary Cirrhosis. Chinese Primary Medicine, 29(05): 660–663.

Sun Y, Wang H, Zhang R, et al., 2022, Effect of Tonic Lung Huayu Tang Combined with Albumin Paclitaxel + Cisplatin Chemotherapy Regimen on the Levels of Squamous Cell Carcinoma Antigen and Helper T Lymphocyte 17/Regulatory T Lymphocytes in Patients with Advanced Squamous Lung Cancer. Hebei Chinese Medicine, 44(03): 420–424.

Zeng Y, Li G, Li H, et al., 2022, Efficacy of Ursodeoxycholic Acid in the Treatment of Patients with Primary Biliary Cholangitis and the Effect on Serum Nrf2 and HO-1 Levels. Journal of Practical Liver Diseases, 25(02): 211–214.

Su Q, Wang Y, Chen H, et al., 2021, Clinical Characteristics of 122 Cases of Autoimmune Hepatitis-Primary Biliary Cholangitis Overlap Syndrome. Journal of Tropical Medicine, 21(07): 916–920 + 949.

Liu Y, Liu H, 2021, Advances in the Study of Molecular Regulatory Mechanisms of Pathogenicity of Helper T Cell 17 Cells. Journal of Modern Traditional Chinese and Western Medicine, 30(21): 2389–394.

Wang Y, Su R, Guo Q, et al., 2021, Association Analysis of Peripheral Blood Helper T Cell 17/Regulatory T Cell Imbalance with Cytokines in Patients with Immunoglobulin G4-Associated Diseases. Chinese Journal of Rheumatology, 25(04): 217–224.

Zhang T, Xu W, Zhou S, 2021, Efficacy of Prednisone Combined with Hesperidin Sodium in the Treatment of Facial Neuritis and the Effect on Regulatory T Cells/Helper T Cells 17 Cytokines and Free Radical Production. Chinese Pharmacoeconomics, 16(03): 95–98.

Li W, Zhou Y, Zhang X, 2020, Peripheral Blood Hypoxia-Inducible Factor-1?, Regulatory T Cells and Helper T Cells 17 and Inflammatory Cytokine Levels in Patients with Nonalcoholic Fatty Liver Disease and Their Correlation. Chinese Journal of Liver Diseases, 12(04): 83–88.

Yang J, Li N, 2020, Advances in the Study of Adjuvant T Lymphocyte 17 in Chronic Inflammatory Liver Disease. Journal of Clinical Hepatobiliary Diseases, 36(12): 2808–2810.

Lin Z, Bian Y, Ma S, et al., 2020, Genome-Wide Microarray-Based Differentiation Study of Helper T Cells 17 in Rats with Experimental Arthritis. Chinese Journal of Clinical Pharmacology, 36(20): 3317–3320.

Li X, 2020, Study on the Expression Level of High Mobility Group Protein B1 on Peripheral Blood of Patients with Primary Dry Syndrome and the Correlation with Helper T Cell 17/Regulatory T Cells, Shanxi Medical University.

Xue M, Mao X, Chen H, 2020, Characteristics of Changes in Auxiliary T Lymphocyte 17/Regulatory T Lymphocyte Ratio Imbalance in a Rat Model of Immune Liver Injury. Journal of Clinical Hepatobiliary Diseases, 36(01): 149–152.

Schmidt T, Chen L, Li W, 2019, Frequency of Helper T Lymphocyte 17 Is Associated with Low Bone Mass in Primary Sclerosing Cholangitis. Journal of Clinical Hepatobiliary Diseases, 35(03): 569.

Li X, Shi Y, Yang X, 2018, Effect and Significance of Gemcitabine on Helper T-Cell 17/CD4+CD25+ Regulatory T Cells and Tumor-Associated Macrophages in Patients with Cervical Cancer. Anhui Medicine, 22(11): 2245–2250.